Patnaik, Amita
START Center for Cancer Care,
United States
2025 Rank: 97619
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2980 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97619 | 109316 |
| Total Cites | 1830 | 1869 |
| H-index | 21 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 159 | 162 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 216 | 220 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1604 | 1641 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
2.09%
|
|
Patnaik, Amita
START San Antonio,
United States
2024 Rank: 73014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2394 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73014 | 81942 |
| Total Cites | 2130 | 2188 |
| H-index | 21 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 213 | 217 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 280 | 286 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1824 | 1870 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.17 |
| Self-Citation Percentage |
2.65%
|
|
Patnaik, Amita
South Texas Accelerated Research Therapeutics (START),
United States
2023 Rank: 72314
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2618 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72314 | 83236 |
| Total Cites | 2231 | 2317 |
| H-index | 22 | 22 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 224 | 230 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 307 | 313 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1900 | 1968 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
3.71%
|
|
Patnaik, Amita
SAN ANTONIO,
United States
2022 Rank: 56624
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2146 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56624 | 66004 |
| Total Cites | 2681 | 2779 |
| H-index | 24 | 24 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 243 | 253 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 342 | 352 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2232 | 2300 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
3.53%
|
|
Patnaik, Amita
South Texas Accelerated Research Therapeutics,
United States
2021 Rank: 60556
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2192 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60556 | 68532 |
| Total Cites | 4175 | 4337 |
| H-index | 26 | 27 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 401 | 420 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 534 | 555 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3422 | 3531 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
3.74%
|
|
Patnaik, Amita
South Texas Accelerated Research Therapeutics,
United States
2020 Rank: 59158
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2057 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59158 | 66427 |
| Total Cites | 2992 | 3163 |
| H-index | 21 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 288 | 299 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 384 | 397 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2411 | 2520 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
5.41%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.